Kyle Michael Wool, Director at AIkido Pharma Inc. (AIKI), bought 5,000 shares at $3.56 ($18K) on 2022-12-08, disclosed to the SEC on 2022-12-12.
Open-market purchase of $18k AIKI by Director. Below the thresholds we flag for high-conviction alerts (no C-suite role, rare reversal, cluster, or A-grade history). Context: insider career grade B.
Clearly above the average filing.
| Filing → |
| DOMH | BUY | 2025-12-10 | $97K | — | Filing → |
| DOMH | BUY | 2024-05-31 | $11K | — | Filing → |
| DOMH | BUY | 2024-04-10 | $13K | — | Filing → |